Showing results (561-570 of 5,265) with videos related to
Sort By:
Pageof 527
European Journal of Haematology|September 25, 2002
Elevated soluble urokinase plasminogen activator receptor in plasma from patients with idiopathic myelofibrosis or polycythaemia veraMorten Krogh Jensen, Rikke Riisbro, Peter de Nully Brown, et al.European Journal of Haematology|May 9, 2002
Drugs elevating extracellular adenosine promote regeneration of haematopoietic progenitor cells in severely myelosuppressed mice: their comparison and joint effects with the granulocyte colony-stimulating factorMichal Hofer, Milan Pospísil, Vladimír Znojil, et al.European Journal of Haematology|March 13, 2003
Role of variant Creutzfeldt-Jakob disease for safety of treatment with blood components: screening of lymphatic tissue is a potential tool for risk assessmentC Sachse, M H Groschup, R Warzok, et al.European Journal of Haematology|March 13, 2003
Evidence for a bimodal relation between serum lysozyme and prognosis in 232 patients with acute myeloid leukaemiaMaria Aström, Lennart Bodin, Per Hörnsten, et al.European Journal of Haematology|March 13, 2003
Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and beta 2-microglobulin in multiple myelomaEvangelos Terpos, Nora Viniou, Josu de la Fuente, et al.European Journal of Haematology|March 27, 2003
Lymphoproliferative disease of granular lymphocytes with T-cell receptor gamma delta-positive phenotype: restricted usage of T-cell receptor gamma and delta subunit genesHideki Makishima, Fumihiro Ishida, Hiroshi Saito, et al.European Journal of Haematology|March 27, 2003
Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinibFrédéric Morel, Marie-Josée Le Bris, Angèle Herry, et al.European Journal of Haematology|March 27, 2003
Signet ring-like light chain myeloma with systemic spreadJoud H Haidar, Ali Bazarbachi, Michel R Nasr, et al.European Journal of Haematology|October 31, 2002
Standard-dose anti-CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia: results from a Nordic multicentre studyM Itälä, C H Geisler, E Kimby, et al.European Journal of Haematology|October 31, 2002
Can t(8;21) oligoblastic leukemia be called a myelodysplastic syndrome?Kinuyo Kaneda, Kensuke Kojima, Makoto Takeuchi, et al.Pageof 527